Pediatric Formulations: A Roadmap - Couverture rigide

Couverture rigide

ISBN 10 : 3031772393 ISBN 13 : 9783031772399

Editeur : Springer International Publishing AG, 2026

Synopsis

Since the first edition in 2014 pediatric drug development has expanded in several dimensions. This is not a “how to formulate“ textbook, but an attempt to equip the reader with necessary information on the technical, the regulatory, and the historical level.

A propos du livre

À propos de l'auteur

Professor Hannah Batchelor is a pharmaceutical scientist who has worked in academia, the NHS and within pharmaceutical industry. She is currently based at the Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde in Glasgow. She is Director of Research for the Strathclyde Institute of Pharmacy and Biomedical Sciences.

She works on the design and manipulation of medicines to create age appropriate drug formulations to maximise clinical efficacy in paediatric patients. Her research interests lie in the optimisation of drug formulations to maximise their biopharmaceutical performance and acceptability to children. Her research is informed by the views of children, young people and parents to ensure that the patients are at the centre of new developments. She is also the director of the GIBio facility at Strathclyde which is an advanced dissolution apparatus designed to provide near clinical data to inform formulation development.

Hannah is passionate about pharmaceutical sciences and is motivated to inspire the next generation of scientists.

Dr. Klaus Rose is CEO of klausrose Consulting, Switzerland and advises on pediatric drug development and how to comply with FDA and EMA pediatric requirements. He has studied Latin languages, psychology and medicine. After postgraduate clinical training in general medicine in Germany and England, he joined the pharmaceutical industry. He has held various positions in R&D and medical affairs, was Global Head Pediatrics Novartis from 2001 to 2005 and was Global Head Pediatrics Roche from 2005 to 2009. After a year with a regulatory consultancy, he established his own business. Dr. Rose is a frequent speaker on international conferences on pediatric drug development, organizes trainings and publishes on a regular base.

Détails de l'édition

• Éditeur: Springer International Publishing AG
• Date d'édition: 2026
• Langue: anglais
• ISBN 10: 3031772393
• ISBN 13: 9783031772399
• Reliure: Relié
• Numéro d'édition: 2
• Nombre de pages: 475
• Éditeur: Batchelor Hannah, Rose Klaus
• Coordonnées du fabricant: ProductSafety@springernature.com; ProductSafety@springernature.com; ; Poststr. 9; Darmstadt; 64293; Allemagne